84 related articles for article (PubMed ID: 15182505)
21. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
22. Recovery of normal DNA repair and mutagenesis in trichothiodystrophy cells after transduction of the XPD human gene.
Marionnet C; Quilliet X; Benoit A; Armier J; Sarasin A; Stary A
Cancer Res; 1996 Dec; 56(23):5450-6. PubMed ID: 8968100
[TBL] [Abstract][Full Text] [Related]
23. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.
Manuguerra M; Saletta F; Karagas MR; Berwick M; Veglia F; Vineis P; Matullo G
Am J Epidemiol; 2006 Aug; 164(4):297-302. PubMed ID: 16707649
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
25. Post-replicative base excision repair in replication foci.
Otterlei M; Warbrick E; Nagelhus TA; Haug T; Slupphaug G; Akbari M; Aas PA; Steinsbekk K; Bakke O; Krokan HE
EMBO J; 1999 Jul; 18(13):3834-44. PubMed ID: 10393198
[TBL] [Abstract][Full Text] [Related]
26. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
[TBL] [Abstract][Full Text] [Related]
27. The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population.
Yin J; Li J; Ma Y; Guo L; Wang H; Vogel U
Cancer Lett; 2005 Jun; 223(2):219-26. PubMed ID: 15896456
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy.
Huang MY; Tsai HL; Lin CH; Huang CW; Ma CJ; Huang CM; Chai CY; Wang JY
J Surg Oncol; 2013 Dec; 108(7):457-64. PubMed ID: 23996617
[TBL] [Abstract][Full Text] [Related]
30. Associations between ERCC2 polymorphisms and gliomas.
Caggana M; Kilgallen J; Conroy JM; Wiencke JK; Kelsey KT; Miike R; Chen P; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):355-60. PubMed ID: 11319176
[TBL] [Abstract][Full Text] [Related]
31. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
32. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
[TBL] [Abstract][Full Text] [Related]
33. DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.
Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G
DNA Repair (Amst); 2012 Apr; 11(4):374-80. PubMed ID: 22284908
[TBL] [Abstract][Full Text] [Related]
34. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
35. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
36. Analysis of uracil DNA glycosylase in human colorectal cancer.
Dusseau C; Murray GI; Keenan RA; O'Kelly T; Krokan HE; McLeod HL
Int J Oncol; 2001 Feb; 18(2):393-9. PubMed ID: 11172609
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer.
Harms C; Salama SA; Sierra-Torres CH; Cajas-Salazar N; Au WW
Environ Mol Mutagen; 2004; 44(1):74-82. PubMed ID: 15199549
[TBL] [Abstract][Full Text] [Related]
38. Human 3-methyladenine-DNA glycosylase: effect of sequence context on excision, association with PCNA, and stimulation by AP endonuclease.
Xia L; Zheng L; Lee HW; Bates SE; Federico L; Shen B; O'Connor TR
J Mol Biol; 2005 Mar; 346(5):1259-74. PubMed ID: 15713479
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer.
Ye X; Ling B; Xu H; Li G; Zhao X; Xu J; Liu J; Liu L
Medicine (Baltimore); 2020 Apr; 99(16):e19755. PubMed ID: 32311975
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of GST-pi and PCNA expression to prognosis of advanced maxillary sinus squamous cell carcinoma].
Guo GF; Xie RH; Yang AK; Chen ZH; Wu QL; Liu WW; Ou SM; Xia LP; Chen MY; Zhang JX
Ai Zheng; 2005 Oct; 24(10):1267-71. PubMed ID: 16219146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
